@FierceMedDev: Seventh Sense revs up crucial trial for microneedle blood collector. More | Follow @FierceMedDev
@MarkHFierce: The NYT has come out against not just a device tax repeal, but industry lobbying efforts to make their case. Story | Follow @MarkHFierce
@DamianFierce: AbioMed is studying a next-gen Impella pump targeting FDA approval. Article |& Follow @DamianFierce
> Medtronic ($MDT) snagged FDA clearance for its Affinity Fusion device, a next-generation oxygenation system for cardiac surgery. Release
> Welch Allyn launched a new FlexiPort EcoCuff, a single-patient-use blood pressure cuff the company says can both cut down on hospital-borne contamination and environmental impacts. More
> California's NuvoLase won a CE mark for its PinPointe FootLaser, designed to treat nail fungus. News
> Kimberly-Clark Health Care bought device maker Life Tech's ($LIFE) anesthesia business for an undisclosed amount. Item
> The Korea Food and Drug Administration changed its name to the Ministry of Food and Drug Safety as part of a regulatory reorganization that will affect both device and drug companies doing business there. Blog
> Many multiple sclerosis patients had hoped an implantable balloon treatment for the condition might succeed where drugs have failed, but a rigorous test of the method found no significant benefit. Article
> Bacterin International's president and CEO Guy Cook said he will resign, though he'll stay on in the interim as the board looks for a successor. Story
> SafeStitch Medical raised $3 million in a private placement that will fund development of disposable devices for minimally invasive gastroenterology procedures. Story
Biotech News
@FierceBiotech: Karolinska portfolio biotech Axelar says PhII lung cancer drug on promising track. More | Follow @FierceBiotech
@JohnCFierce: Clavis' Olav Hellebo says co. could be sold or shut down, but it's all down to liquidation value now. More | Follow @JohnCFierce
@RyanMFierce: Immunomedics won an $18M settlement from BoA, now it could use an R&D win with those cancer programs. WSJ Article | Follow @RyanMFierce
> Obama seeks revolutionary brain discoveries on a budget. Story
> Analysis: No quick fix in sight for AstraZeneca's PhIII woes. More
> PolyMedix defaults and hands over a PhII antibiotic to bankruptcy court. News
Pharma News
@FiercePharma: Lilly works up $180M addition to Indy insulin mfring + $80M in other projects. PR hints at city tax incentives: Release | Follow @FiercePharma
@EricPFierce: Recalls by Hospira encourage other players to jump into sterile injectable drug manufacturing. More | Follow @EricPFierce
> Merz swoops into Obagi deal with $385M bid, topping Valeant. More
> AZ's Pulmicort patent loss could cost $100M-plus. Story
Biotech Research News
@EmilyMFierce: Waiting for details today on Obama's $100M brain mapping project. Background here: Story | Follow @EmilyMFierce
> More evidence found for new anti-cancer agent. More
> Diabetes drug slows aging process in worms. Report
> Researchers launch consortium to study neurodegenerative diseases. Item
> Dutch researchers detect early Parkinson's pathology. Article
> New drug could combat resistant malaria strains. More
Pharma Manufacturing News
> Manufacturing issues still dog A.P. Pharma. Story
> Japan's Asada Milling gets warning letter. More
> Lilly doubles down on insulin plant, expands API capacity. Article
> Sanofi adding manufacturing capacity in China, Vietnam. Story